P193 USEFUL I: musculoskeletal ultrasound to identify patients with lupus arthritis with better response to therapy by Mahmoud, Khaled et al.
Article
P193 USEFUL I: musculoskeletal ultrasound to 
identify patients with lupus arthritis with better 
response to therapy
Mahmoud, Khaled, Zayat, Ahmed S, Yusof, Md Yuzaiful Md, Dutton, 
Katherine, Teh, Lee Suan, Yee, Chee-Seng, D’Cruz, David, Ng, Nora, 
Isenberg, David, Ciurtin, Coziana and Et, Al
Available at http://clok.uclan.ac.uk/32821/
Mahmoud, Khaled, Zayat, Ahmed S, Yusof, Md Yuzaiful Md, Dutton, Katherine, Teh, Lee 
Suan, Yee, Chee-Seng, D’Cruz, David, Ng, Nora, Isenberg, David et al (2020) P193 
USEFUL I: musculoskeletal ultrasound to identify patients with lupus arthritis with better 
response to therapy. Lupus Science & Medicine, 7 .  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.1136/lupus-2020-eurolupus.235
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
P193 USEFUL I: MUSCULOSKELETAL ULTRASOUND TO
IDENTIFY PATIENTS WITH LUPUS ARTHRITIS WITH
BETTER RESPONSE TO THERAPY
1,2Khaled Mahmoud, 3Ahmed S Zayat, 1,2Md Yuzaiful Md Yusof, 1,2Katherine Dutton, 4Lee
Suan Teh, 5Chee-Seng Yee, 6David D’Cruz, 6Nora Ng, 7David Isenberg, 7Coziana Ciurtin,
1,2Philip Conaghan, 1,2Paul Emery, 8Chris Edwards, 1,2Elizabeth MA Hensor, 1,2Edward
M Vital. 1NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust,
Leeds; 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds,
Leeds, UK; 3Bradford Teaching Hospitals NHS Foundation Trust, Bradford; 4Royal Blackburn
Teaching Hospital, Blackburn and University of Central Lancashire, Preston; 5Doncaster and
Bassetlaw NHS Trust, Doncaster; 6Guys and St Thomas Hospital, London; 7University
College London, London; 8University Hospital Southampton NHS Foundation Trust,
Southampton
10.1136/lupus-2020-eurolupus.235
Background In SLE, musculoskeletal manifestations have an
impact on quality of life, disability and clinical trial outcomes,
but are harder to assess than in RA and PsA. We previously
showed that joint swelling lacks sensitivity, specificity and
responsiveness compared to ultrasound. USEFUL was a multi-
centre longitudinal study to determine clinical features predict-
ing ultrasound synovitis and whether patients with ultrasound
synovitis respond better to therapy.
Methods SLE patients were recruited if the referring physician
deemed they had inflammatory pain warranting treatment.
Swollen joints were not required. At baseline, physicians
recorded the features that led them to diagnose inflammatory
pain and features of concurrent fibromyalgia and osteoarthri-
tis. Stable doses of prednisolone (£5 mg/day), antimalarials or
immunosuppressants were allowed. Participants received depo-
medrone 120 mg IM then were assessed at 0, 2 and 6 weeks
for 66/68 swollen and tender joint counts, BILAG-2004, SLE-
DAI-2K, physician global and MSK-VAS, inflammatory
markers, patient pain and disease activity-VAS, HAQ-DI,
LupusQoL, ultrasound of hands and wrists (blinded to patient
and clinical assessor). An internal pilot determined the primary
endpoint: EMS-VAS at 2 weeks (adjusted for baseline) between
patients with ultrasound-synovitis vs. normal ultrasound at
baseline. Sensitivity analyses adjusted for prednisolone and
immunosuppressants.
Results 122/133 patients recruited completed all visits. There
was significant disagreement between clinical examination and
ultrasound. 78/133 had ultrasound synovitis; 68% of these
had 1 swollen joint. Of 66/133 patients with  1 swollen
joint, 20% had normal ultrasound.
Ultrasound-synovitis was more likely with joint swelling, a
symmetrical small joint distribution and active serology. Physi-
cian-determined EMS, other lupus features or prior response
to therapy were not associated. Fibromyalgia or osteoarthritis
did not reduce the probability of ultrasound synovitis.
In the full analysis set (n=133) there was no difference in
EMS VAS at 2 weeks according to ultrasound synovial status as
baseline (difference -8 mm, 95% CI -19, 4 mm, p=0.178). 32
patients had fibromyalgia. After excluding these patients, we
found a statistically and clinically significantly better clinical
response to depomedrone in patients with ultrasound-synovitis
at baseline (baseline-adjusted EMS VAS at 2 weeks -12 mm,
95% CI -24, 0 mm, p=0.049). This difference was greater in
the treatment-adjusted sensitivity analysis (-12.8 (95% CI -22, -3
mm), p=0.007) and the per-protocol-adjusted sensitivity analysis
(-14.8 mm (95% CI -20.8, -8.8 mm), p<0.001). Patient with
ultrasound synovitis had higher rates of improvement in the
musculoskeletal BILAG-2004 (56% vs. 26%, p=0.09) and SLE-
DAI-2K (37% vs. 15%, p=0.03).
Conclusions In lupus arthritis distribution and serology, but
not other features, help identify ultrasound-synovitis. Ultra-
sound-synovitis was independent of features of fibromyalgia,
but fibromyalgia confounded assessment of response. Exclud-
ing fibromyalgia, response to therapy was better in patients
with abnormal ultrasound compared to normal. Ultrasound
should be used to select patients for therapy and clinical trials,
especially when there are inflammatory symptoms without
swollen joints.
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